High positive predictive value 22q11.2 microdeletion screening by prenatal cell‐free DNA testing that incorporates fetal fraction amplification

Overview of attention for article published in Prenatal Diagnosis, April 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#9 of 2,445)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 36 news outlets

twitter: 6 X users

Summary News X

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 15,499 followers.

#MasonOH @myriadgenetics is celebrating #LabWeek April 15-20. Their research impacts lives and influences decisions that make the #HealthCare & #bio industries stronger. #MasonLivingLab @GeneSight @GrowCincyUSA

18 Apr 2024

Reply Repost Favourite

High positive predictive value 22q11.2 microdeletion screening by prenatal cell-free DNA testing that incorporates fetal fraction amplification https://t.co/O3jgkPBQgq

17 Apr 2024

Reply Repost Favourite

RT @ISPDHQ: Prenatal Diagnosis: High positive predictive value 22q11.2 microdeletion screening by prenatal cell‐free DNA testing that inco…

17 Apr 2024

Reply Repost Favourite

RT @myriadgenetics: New data from Myriad - Up to 100% positive predictive value (PPV) for 22q11.2 microdeletion syndrome using Prequel® wit…

16 Apr 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.